经皮电刺激足三里及上巨虚穴预防妇科腹腔镜术后恶心呕吐的效果

注册号:

Registration number:

ITMCTR2100004995

最近更新日期:

Date of Last Refreshed on:

2021-06-28

注册时间:

Date of Registration:

2021-06-28

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

经皮电刺激足三里及上巨虚穴预防妇科腹腔镜术后恶心呕吐的效果

Public title:

Effect of percutaneous electrical stimulation of Zusanli and Shangjuxu acupoints on preventing postoperative nausea and vomiting after gynecological laparoscopic surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮电刺激足三里及上巨虚穴预防妇科腹腔镜术后恶心呕吐的效果

Scientific title:

Effect of percutaneous electrical stimulation of Zusanli and Shangjuxu acupoints on preventing postoperative nausea and vomiting after gynecological laparoscopic surgery

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2100047967 ; ChiMCTR2100004995

申请注册联系人:

龙学晨

研究负责人:

郭文俊

Applicant:

Long Xuechen

Study leader:

Guo Wenjun

申请注册联系人电话:

Applicant telephone:

+86 18315305065

研究负责人电话:

Study leader's telephone:

+86 13605532244

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

458844740@qq.com

研究负责人电子邮件:

Study leader's E-mail:

gwj8581@sina.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

安徽省芜湖市赭山西路2号

研究负责人通讯地址:

安徽省芜湖市赭山西路2号

Applicant address:

2 Zheshan Road West, Wuhu, Anhui

Study leader's address:

2 Zheshan Road West, Wuhu, Anhui

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

皖南医学院弋矶山医院

Applicant's institution:

Yijishan Hospital of Wannan Medical College

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013/8/26 0:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

皖南医学院弋矶山医院

Primary sponsor:

Yijishan Hospital of Wannan Medical College

研究实施负责(组长)单位地址:

安徽省芜湖市赭山西路2号

Primary sponsor's address:

2 Zheshan Road West, Wuhu, Anhui

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽

市(区县):

芜湖

Country:

China

Province:

Anhui

City:

Wuhu

单位(医院):

皖南医学院弋矶山医院

具体地址:

赭山西路2号

Institution
hospital:

Yijishan Hospital of Wannan Medical College

Address:

2 Zheshan Road West

经费或物资来源:

皖南医学院麻醉学院

Source(s) of funding:

School of Anesthesiology, Wannan Medical College

研究疾病:

术后恶心呕吐

研究疾病代码:

Target disease:

Postoperative nausea and vomiting (PONV)

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

1.观察经皮电刺激足三里及上巨虚穴的安全性,单独应用能否降低妇科腹腔镜手术PONV的发生率,两组穴位联合应用是否具有协同作用。 2.观察经皮电刺激足三里及上巨虚穴对术中血压、术后苏醒时间及术后疼痛的影响。

Objectives of Study:

1. To observe the safety of percutaneous electrical stimulation of Zusanli and Shangjuxu acupoints, whether single application can reduce the incidence of PONV in gynecological laparoscopic surgery, and whether the combined application of two groups of acupoints has a synergistic effect. 2. To observe the effects of percutaneous electrical stimulation of Zusanli and Shangjuxu acupoints on intraoperative blood pressure, postoperative recovery time and postoperative pain.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1.年龄18 ~65 岁; 2.ASA 分级:I ~ Ⅲ级; 3.女性,择期行腔镜下妇科手术; 4.采用全凭静脉麻醉; 5.BMI:18~24 kg/m^2。

Inclusion criteria

1. Aged 18 to 65 years; 2. ASA classification: I-III; 3. Female, elective laparoscopic gynecological surgery; 4. Use total intravenous anesthesia; 5. BMI 18-24 kg/m^2.

排除标准:

1.严重精神疾患; 2.合并严重肝、肾等系统疾病; 3.术前24小时内使用过止吐药物或发生过恶心呕吐的患者; 4.严重的胃肠疾病患者; 5.吸烟,晕动病史患者。

Exclusion criteria:

1. Severe mental illness; 2. Combined with severe liver, kidney and other system diseases; 3. Patients who have used antiemetic drugs or experienced nausea and vomiting within 24 hours before surgery; 4. Patients with severe gastrointestinal diseases; 5. Patients with a history of smoking and motion sickness.

研究实施时间:

Study execute time:

From 2021-07-01

To      2021-09-30

征募观察对象时间:

Recruiting time:

From 2021-07-01

To      2021-09-30

干预措施:

Interventions:

组别:

3组

样本量:

40

Group:

Group 3

Sample size:

干预措施:

经皮电刺激上巨虚穴

干预措施代码:

Intervention:

Transcutaneous electrical stimulation of Shangjuxu acupoint

Intervention code:

组别:

1组

样本量:

40

Group:

Group 1

Sample size:

干预措施:

不使用经皮电刺激

干预措施代码:

Intervention:

No transcutaneous electrical stimulation

Intervention code:

组别:

4组

样本量:

40

Group:

Group 4

Sample size:

干预措施:

经皮电刺激足三里及上巨虚穴

干预措施代码:

Intervention:

Transcutaneous electrical stimulation of Zusanli and Shangjuxu acupoints

Intervention code:

组别:

2组

样本量:

40

Group:

Group 2

Sample size:

干预措施:

经皮电刺激足三里穴

干预措施代码:

Intervention:

Transcutaneous electrical stimulation of Zusanli acupoint

Intervention code:

样本总量 Total sample size : 160

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

安徽

市(区县):

芜湖

Country:

China

Province:

Anhui

City:

Wuhu

单位(医院):

皖南医学院弋矶山医院

单位级别:

三级甲等

Institution/hospital:

Yijishan Hospital of Wannan Medical College

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后疼痛

指标类型:

次要指标

Outcome:

Postoperative pain

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后恶心

指标类型:

主要指标

Outcome:

Postoperative nausea

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术中血压

指标类型:

次要指标

Outcome:

Intraoperative blood pressure

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后呕吐

指标类型:

主要指标

Outcome:

Postoperative vomiting

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

苏醒时间

指标类型:

次要指标

Outcome:

Recovery time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 65
Max age years

Recruiting status:

Participant age:

性别:

Gender:

女性

Female

随机方法(请说明由何人用什么方法产生随机序列):

随机数表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table

盲法:

Not stated

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

论文形式发表

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

paper published

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据管理委员会:

Data Managemen Committee:

No

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统